Skip to main content


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

White Paper

Meeting the New Regulatory Requirements in Sartan API Production

Manufacturer of APIs are now required to review their manufacturing processes and prove the absence of nitrosamine impurities. This whitepaper outlines the regulations and a case study on how Dr. Reddy’s Sartan API’s (such as Valsartan) already addresses future requirements.

You can review our Sartan portfolio by clicking on the following links:

Valsartan - https://api.drreddys.com/product/valsartan

Losartan - https://api.drreddys.com/product/losartan-potassium

Telmisartan - https://api.drreddys.com/product/telmisartan

Irbesartan - https://api.drreddys.com/product/irbesartan

Explore other Whitepapers:

Know More

Download Now

Please fill the Contact form below in order to view the white paper

Meet with our product experts in one-on-one virtual sessions

Our experts will answer your questions, provide advice, and help you understand our product better

Set Up a Meeting
X

API
Active Pharmaceutical Ingredients

API Supplier of the Year

Global Generics & Biosimilars Awards 2021 winner for 3 consecutive years!

Explore our Products